Similar Items: Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 entry inhibitors
- Characterizing the immune response to HIV-1 using host derived epitope R7V
- Functional miRNA-based Phenotypic Screening as a tool to delineate HIV-host interactions and facilitate Novel Drug Discovery
- Generation and analysis of mutated clonal scFv antibody fragments against R7V epitope of HIV-1
- An in-depth analysis of comorbidities in the context of HIV burden, in a cohort of patients seeking healthcare at Khayelitsha facilities in 2016-2017
- HIV and the right to sanitation in the context of conflict and internal displacement in the Democratic Republic of Congo
- Comparative effects of antiretroviral treatments on metabolomics, cytokine profiles and platelet activation in HIV-positive individuals
Author: Gama, Ntombenhle Hlengiwe
- Platinum and palladium complexes as human immunodeficiency virus latency reversal agents
- The HIV-1 entry inhibition capabilities of Isoflavones
- The in vitro anti-cancer activity of gold, palladium and platinum-based metallodrugs
- Anti-HIV, anticancer and antioxidant activity of Fockea multiflora extracts
- In vitro anticancer activity of novel organometallic gold and ruthenium complexes
- Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 entry inhibitors